For the Inventor, By the Inventor

Enter assignee name

Milford, MA, United States of America

Avecia Biotechnology, Inc.

USPTO Granted Patents = 19

CIPO Patents = 7

EPO Patents = 4

Trademarks = 3

Forward Citations = 179

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Nanda Dulal Sinha (8 out of 8 patents)

Jin-Yan Tang (6 out of 17 patents)

Paul McCormac (3 out of 3 patents)

4. Satya Kuchimanchi (2 out of 2 patents)

5. William Edward Zedalis (2 out of 2 patents)

6. Gregory Keith Miranda (2 out of 2 patents)

7. Donald Alfred Wellings (2 out of 7 patents)

8. David John Moody (2 out of 2 patents)

9. Zhaoda Zhang (2 out of 2 patents)

10. Andrew Guy Livingston (1 out of 17 patents)

11. Andrew Timothy Boam (1 out of 9 patents)

12. Guangrong Zhang (1 out of 2 patents)

13. Saied Shaikh (1 out of 1 patent)

14. Dinesh Nair (1 out of 1 patent)

15. Stephen Hargreaves (1 out of 1 patent)

19 patents: Sort by Forward Citations

1. 8193337 - Oxidation process (2012-06-05),

2. 8163891 - Process for the preparation of poly(alkoxylated) oligonucleotides (2012-04-24),

3. 8093397 - Activators for oligonucleotide synthesis (2012-01-10),

4. 7960542 - Process for purifying oligonucleotide synthons (2011-06-14),

5. 7872121 - Process for the removal of exocyclic base protecting groups (2011-01-18),

6. 7635772 - Process for the preparation of oligonucleotides (2009-12-22),

7. 7560555 - Process for the preparation of phosphitylation agents (2009-07-14),

8. 7501505 - Activators for oligonucleotide synthesis (2009-03-10),

9. 7476709 - Process for preparing oligonucleotides (2009-01-13),

10. 7365132 - Monomers containing polyoxyalkylenes and polymer supports therefrom (2008-04-29),

11. 7247720 - Phosphitylation process (2007-07-24),

12. 7230095 - Immobilization of oligonucleotides onto solid supports (2007-06-12),

13. 7038027 - Method of preventing modification of synthetic oligonucleotides (2006-05-02),

14. 6538128 - Detritylation solvents for nucleic acid synthesis (2003-03-25),

15. 6500944 - Sulfurizing reagent: 3-aryl-1,2,4-dithiazoline-5-ones (2002-12-31),

Avecia Biotechnology, Inc. is a leading biotechnology company that specializes in advanced gene therapy solutions. With a dedicated focus on developing innovative treatments, we aim to revolutionize healthcare by harnessing the power of gene editing and delivery technologies. Our team of experts is committed to transforming patient care and improving quality of life through cutting-edge biotechnology advancements.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

19 Patents

#9 in Milford, MA

#1,006 in Massachusetts

#16,595 in US

#31,677 in the World

Milford, MA, United States of America

Avecia Biotechnology, Inc.

Forward Citations = 179

22 inventors:

Nanda Dulal Sinha (8 out of 8 patents)

Jin-Yan Tang (6 out of 17 patents)

Paul McCormac (3 out of 3 patents)

4. Satya Kuchimanchi (2 out of 2 patents)

5. William Edward Zedalis (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…